Avera Research Institute Participating in Fibromyalgia Study

SIOUX FALLS, SD (June 2007) – The Avera Research Institute is enrolling patients in a research study to determine the effectiveness of adding cognitive-behavioral therapy (CBT) in an experimental format to standard medical care for the treatment of Fibromyalgia (FMS).

“This research opportunity is not only unique in how to treat people with Fibromyalgia, but also unique in how it delivers this treatment,” observes Dr. Manish Sheth, with the Avera Research Institute. “This study could have a great impact on improving the health of people who suffer from Fibromyalgia.”

Men and women over the age of 18 who have been diagnosed with Fibromyalgia and have been receiving standard medical care with a physician for at least three months may be eligible to participate. Also, participants in this study must have access to a computer and to the internet. Participation in this study will last for 6 months.

This study will examine the health and economic benefits of adding CBT to the standard medical care treatment of Fibromyalgia. CBT is a non-drug intervention that uses educational instruction in lifestyle changes to promote health. A self-management FMS website will contain the self-management skills commonly taught in CBT, the ability to confidentially e-mail others with FMS, and the ability to send information about healthcare use to the researchers.

Fibromyalgia is one of the most frequent illnesses seen in pain and rheumatology clinics. Although it is not fatal, FMS can significantly reduce functioning in many aspects of life. Fibromyalgia is a syndrome of chronic widespread pain, fatigue, sleep disorders and memory complaints, affecting over 10 million Americans.

Individuals interested in the study may contact the Avera Research Institute at (605) 322-3050 or toll-free at (888) 634-7268. Click here to see what studies are currently enrolling participants.